Towards a treatment for gluten intolerance

Heidelberg, 30 November 2018 – Celiac disease is a severe autoimmune disorder of the intestine. It occurs when people develop sensitivity to gluten, a substance found in wheat, rye, and barley. An international research team from Italy and France has now uncovered a new molecular player in the development of gluten intolerance. Their discovery, published in The EMBO Journal, suggests potential targets for the development of therapeutic approaches for the disease. (Mehr in: Pressemitteilungen – idw – Informationsdienst Wissenschaft)